Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Apr. 30, 2024 $ 10,732 $ 90,297,824 $ (72,848,101) $ 17,460,455
Balance, shares at Apr. 30, 2024 10,732,277      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Net loss (4,325,305) (4,325,305)
Stock-based compensation in connection with restricted common stock award grants and restricted common stock unit grants 9,375 9,375
Balance at Jul. 31, 2024 $ 10,732 90,314,601 (77,173,406) 13,151,927
Balance, shares at Jul. 31, 2024 10,732,277      
Balance at Apr. 30, 2024 $ 10,732 90,297,824 (72,848,101) 17,460,455
Balance, shares at Apr. 30, 2024 10,732,277      
Net loss       (12,789,849)
Balance at Jan. 31, 2025 $ 12,348 103,092,814 (85,637,950) 17,467,212
Balance, shares at Jan. 31, 2025 12,348,116      
Balance at Jul. 31, 2024 $ 10,732 90,314,601 (77,173,406) 13,151,927
Balance, shares at Jul. 31, 2024 10,732,277      
Issuance of common stock for services including accrued and prepaid services $ 30 119,970 120,000
Issuance of common stock for services including accrued and prepaid services, shares 30,212      
Issuance of common stock for exercise of stock warrants $ 15 67,185 67,200
Issuance of common stock for exercise of stock warrants, shares 15,000      
Accretion of stock based compensation in connection with stock option grants 7,402 7,402
Net loss (2,102,527) (2,102,527)
Issuance of common stock for vested restricted and deferred stock unit $ 8 (8)
Issuance of common stock for vested restricted and deferred stock unit, shares 7,927      
Balance at Oct. 31, 2024 $ 10,785 90,509,150 (79,275,933) 11,244,002
Balance, shares at Oct. 31, 2024 10,785,416      
Issuance of common stock for exercise of stock warrants $ 105 508,295 508,400
Accretion of stock based compensation in connection with stock option grants 997,496 997,496
Net loss (6,362,017) (6,362,017)
Issuance of common stock, net of issuance cost 1,458 10,145,643 10,147,101
Issuance of common stock for vested restricted and deferred stock unit 932,230 932,230
Issuance of common stock for vested restricted and deferred stock unit, shares      
Balance at Jan. 31, 2025 $ 12,348 103,092,814 (85,637,950) 17,467,212
Balance, shares at Jan. 31, 2025 12,348,116      
Balance at Oct. 31, 2024 $ 10,785 90,509,150 (79,275,933) 11,244,002
Balance, shares at Oct. 31, 2024 10,785,416      
Issuance of common stock for exercise of stock warrants, shares 105,000      
Issuance of common stock, net of issuance cost, shares 1,457,700      
Balance at Jan. 31, 2026 $ 16,455 157,821,391 (105,251,112) 52,586,734
Balance, shares at Jan. 31, 2026 16,455,121      
Balance at Apr. 30, 2025 $ 12,693 104,980,837 (93,407,223) 11,586,307
Balance, shares at Apr. 30, 2025 12,692,784      
Issuance of common stock for services including accrued and prepaid services $ 32 251,277 251,309
Issuance of common stock for services including accrued and prepaid services, shares 32,049      
Issuance of common stock for exercise of stock options $ 3 13,201 13,204
Issuance of common stock for exercise of stock options, shares 2,742      
Issuance of common stock for exercise of stock warrants $ 1,038 6,481,974 6,483,012
Issuance of common stock for exercise of stock warrants, shares 1,038,384      
Issuance of common stock for cashless exercise of stock warrants $ 260 (260)
Issuance of common stock for cashless exercise of stock warrants, shares 260,071      
Reclassification of warrant liability into equity upon exercise of warrants 10,136,100 10,136,100
Accretion of stock based compensation in connection with stock option grants 79,746 79,746
Stock-based compensation in connection with restricted common stock award grants and restricted and deferred common stock unit grants 55,267 55,267
Net loss (2,077,499) (2,077,499)
Balance at Jul. 31, 2025 $ 14,026 121,998,142 (95,484,722) 26,527,446
Balance, shares at Jul. 31, 2025 14,026,030      
Balance at Apr. 30, 2025 $ 12,693 104,980,837 (93,407,223) $ 11,586,307
Balance, shares at Apr. 30, 2025 12,692,784      
Issuance of common stock for exercise of stock options, shares       8,631
Net loss       $ (11,843,889)
Balance at Jan. 31, 2026 $ 16,455 157,821,391 (105,251,112) 52,586,734
Balance, shares at Jan. 31, 2026 16,455,121      
Balance at Jul. 31, 2025 $ 14,026 121,998,142 (95,484,722) 26,527,446
Balance, shares at Jul. 31, 2025 14,026,030      
Issuance of common stock for exercise of stock options $ 2 13,202 13,204
Issuance of common stock for exercise of stock options, shares 1,726      
Issuance of common stock for exercise of stock warrants $ 267 1,864,703 1,864,970
Issuance of common stock for exercise of stock warrants, shares 266,665      
Issuance of common stock for cashless exercise of stock warrants $ 52 (52)
Issuance of common stock for cashless exercise of stock warrants, shares 52,240      
Accretion of stock based compensation in connection with stock option grants 79,746 79,746
Stock-based compensation in connection with restricted common stock award grants and restricted and deferred common stock unit grants 55,268 55,268
Net loss (4,482,551) (4,482,551)
Issuance of common stock, net of issuance cost $ 38 523,238 523,276
Issuance of common stock, net of issuance cost, shares 38,541      
Balance at Oct. 31, 2025 $ 14,385 124,534,247 (99,967,273) 24,581,359
Balance, shares at Oct. 31, 2025 14,385,202      
Issuance of common stock for exercise of stock options $ 2 13,202 13,204
Issuance of common stock for exercise of stock options, shares 1,726      
Issuance of common stock for exercise of stock warrants $ 146 1,892,047 1,892,193
Issuance of common stock for exercise of stock warrants, shares 146,034      
Accretion of stock based compensation in connection with stock option grants 111,962 111,962
Stock-based compensation in connection with restricted common stock award grants and restricted and deferred common stock unit grants 99,718 99,718
Net loss (5,283,839) (5,283,839)
Issuance of common stock, net of issuance cost $ 1,922 31,170,215 31,172,137
Issuance of common stock, net of issuance cost, shares 1,922,159      
Balance at Jan. 31, 2026 $ 16,455 $ 157,821,391 $ (105,251,112) $ 52,586,734
Balance, shares at Jan. 31, 2026 16,455,121